AACR

AACR is deeply concerned that proposed OMB regulations would disrupt the process for awarding federal research grants, severely weakening a program that has supported American medical innovation for decades. Learn more: brnw.ch/21x3LeY #UnitedByCancerResearch

@US_FDA The results that led to the approval were presented at the San Antonio Breast Cancer Symposium 2025, which is co-organized by AACR: aacrjournals.org/clincancerres/… #SABCS25 @SABCSSanAntonio

The @US_FDA approved the targeted therapy gedatolisib with fulvestrant—with or without palbociclib—for certain HR-positive, HER2-negative advanced breast cancers that do not have a PIK3CA mutation after progressing on or after prior endocrine therapy: brnw.ch/21x48ji

ICYMI: Injecting immunotherapy into precancerous oral lesions may prevent progression to cancer without surgery, according to clinical trial results reported at #AACR26. Learn more on the #AACRBlog: brnw.ch/21x48jc

The @US_FDA granted traditional approval to the targeted therapy selpercatinib for patients 2 and older with advanced solid tumors that have a RET gene fusion whose disease progressed on or following systemic treatment or who have no alternative options: brnw.ch/21x48f6

Register by August 14 to get the lowest rates for the AACR Conference on Pancreatic Cancer (Sept 25-28; San Diego), chaired by Andrew J. Aguirre, Florencia McAllister, Kenneth P. Olive, Eileen O’Reilly, Diane M. Simeone, and Colin D. Weekes. brnw.ch/21x488M #AACRpan26

Innovative Approaches to Understanding and Addressing Early‑Onset Cancer Disparities: Rebecca Kehm, Cassandra Fritz, Clayton Yates, @TamikaFelder, and Lisa Simms Booth will address this topic in a plenary at #AACRdisp26 (Oct 18-21; Atlanta). brnw.ch/21x47Rf

Register by August 11 to get the lowest rates for the AACR Special Conference on Pediatric Cancer (September 22-25; Philadelphia), chaired by Olivier Delattre, Annie A. Huang, David M. Langenau, and Suzanne P. MacFarland. Learn more: brnw.ch/21x46i7 #AACRpediatric26

The AACR-Debbie’s Dream Foundation Innovation and Discovery Grant is a two-year, $100,000 grant to support investigators examining important and druggable novel targets and/or biomarkers that are relevant to gastric cancer. Apply by July 22: brnw.ch/21x45Xp #AACRGrants

Contact your Members of Congress to share your concerns about OMB's proposed sweeping revisions to the rules for federal grants. These proposed changes would undermine the research that supports lifesaving discoveries and brings new options to patients: aacr.org/professionals/…

There is still time to submit comments on the proposed rules. Submit your comments before 12 am ET.  aacr.org/professionals/…

Today, AACR submitted comments in response to the harmful OMB rule that would severely set back our nation's medical science enterprise and delay the groundbreaking treatments that are pivotal to improving patient outcomes and saving lives. brnw.ch/21x45TY

On the #AACRBlog: Cancer Researchers Explain How OMB's Proposed Changes to Federal Grantmaking Will Cause Delays, Reduce Transparency, and Undermine Merit-based Processes. aacr.org/blog/2026/07/1…

Deadline Today: Submit an abstract by 1:00 PM ET for the AACR Conference on Pancreatic Cancer (Sept 25-28; San Diego), chaired by Andrew J. Aguirre, Florencia McAllister, Kenneth P. Olive, Eileen O’Reilly, Diane M. Simeone, and Colin Weekes. brnw.ch/21x45DO #AACRpan26

An OMB proposal to change how federal grants are awarded and managed would destabilize our nation's medical research enterprise, halt critical clinical trials, slow advances in science and medicine, and jeopardize access to new treatments. Learn more: brnw.ch/21x44G6

Submit an abstract by July 13 for the AACR Conference on Pancreatic Cancer (Sept 25-28; San Diego), chaired by Andrew J. Aguirre, Florencia McAllister, Kenneth P. Olive, Eileen O’Reilly, Diane M. Simeone, and Colin D. Weekes. brnw.ch/21x42wd #AACRpan26 @MadameSurgeon

Cancer researchers explain how certain provisions of the White House Office of Management and Budget’s proposal to change how federal grants are managed will undermine U.S. scientific innovation. Learn more on the #AACRBlog: brnw.ch/21x42re

Sharing your cancer diagnosis with someone can be stressful, especially if it's someone you recently started dating. @CancerTodayMag asked a social worker for advice on how to have that conversation: brnw.ch/21x42l8

Submit an abstract by July 13 for the San Antonio Breast Cancer Symposium (December 8-11), presented by UT Health San Antonio in collaboration with the AACR. Learn more: brnw.ch/21x42kk #SABCS26

The @US_FDA extends a prior approval for pembrolizumab (or pembrolizumab and berahyaluronidase alfa-pmp) with enfortumab vedotin-ejfv both before and after cystectomy to include all adults with muscle-invasive bladder cancer eligible for surgery: brnw.ch/21x42jo